Company news

Share this article:
Schering-Plough and GlaxoSmithKline have awarded the consumer advertising business for Levitra to Havas' Euro RSCG Life following a competitive pitch, according to an AdWeek report. The incumbent agency, Omnicom's BBDO, did not participate in the pitch, AdWeek reported. The assignment has passed through many hands since the launch of the drug five years ago. Before BBDO, the account was handled by Publicis' Saatchi & Saatchi Consumer Healthcare and WPP's Quantum Group. 
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.